Full Text View
Tabular View
No Study Results Posted
Related Studies
Care of the Dry Skin With Physiogel AI Lotion® (W0156)
This study is currently recruiting participants.
Study NCT00663364   Information provided by University Hospital Muenster
First Received: April 14, 2008   Last Updated: February 16, 2009   History of Changes

April 14, 2008
February 16, 2009
April 2008
July 2009   (final data collection date for primary outcome measure)
  • Improvement of dry skin Improvement of burning, stinging and pruritus (if present) Improvement of quality of life [ Time Frame: two weeks ] [ Designated as safety issue: No ]
  • Improvement of burning, stinging and pruritus (if present) [ Time Frame: two weeks ] [ Designated as safety issue: No ]
  • Improvement of quality of life [ Time Frame: two weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00663364 on ClinicalTrials.gov Archive Site
 
 
 
Care of the Dry Skin With Physiogel AI Lotion® (W0156)
Klinische Untersuchung Zur Pflege Trockener Haut Mit Physiogel AI Lotion Und Physiogel Lotion

Dry skin is a physiological condition and is characterized in contrast to greasy skin by roughness, desquamation and lack of brightness of the skin surface. Subjectively, feelings of tension, burning and itching can occur. Dry skin needs special care due to its structural and functional characteristics.We monitor an application test the Dermatocosmetics Oilatum Physiogel AI Lotion and Physiogel Lotion. This is to be accomplished with patients having dry skin. The influence on the roughness of skin, desquamation, feeling of tingle, burning and itching should be documented. If sleep quality is disturbed by tingle or itch, this will be monitored, too.

The included patients use the lotion twice daily for a two-week period. If not sufficient it can be continued up to a four-weeks period. Additionally, the patient receives a documentation sheets to note several parameters. In a sensory assessment, product specific parameter such as spreadability, permeability, lubricating, smell of lotion and cosmetic acceptance during the treatment will be assessed (at the beginning, after 2 weeks, after 4 weeks, 2 weeks after stopping treatment). After four weeks the skin care measurement will be terminated and the patient can continue with a treatment of his choice. A monitoring of at least 50 patients per preparation is intended.

 
Interventional
Supportive Care, Randomized, Open Label, Placebo Control, Single Group Assignment
Eczema
Drug: Physiogel AI Lotion, Physiogel Lotion
  • Active Comparator: Physiogel AI Lotion
  • Active Comparator: Physiogel Lotion twice daily
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
100
September 2009
July 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Patients age: over 18 years
  2. Willing to apply skin care for 2 to 4 weeks, twice daily
  3. Willing to fulfill questionnaires / home diaries: self-perception of roughness of the skin, desquamation of the skin, lack of skin brightness, feelings of tension and itching

Exclusion Criteria:

  1. Participation in any other research study during the previous 4 weeks.
  2. Previous participation in this study.
  3. Concurrent participation in any other research study involving an investigational product.
  4. Current need for the use of topical steroids.
  5. History of skin disease or allergy likely to interfere with the study or known sensitivity to the test product or its ingredients.
  6. Subjects considered unable or unlikely to fulfill diaries.
  7. Employees of (CRO) or Stiefel Laboratories, or an immediate family member (partner, offspring, parents, siblings or sibling's offspring) of an employee.
  8. History of cancer.
  9. Recent immunization (less than 10 days prior to the use of the test product).
Both
18 Years and older
No
Contact: Sonja Ständer, MD +251-8356504
Contact: Dorothee Siepmann, MD +251-8356521
Germany
 
NCT00663364
Sonja Ständer, Prof. Dr., Department of Dermatology, University of Münster
SST-Pr-5-2006
University Hospital Muenster
 
Principal Investigator: Sonja Ständer, MD Department of Dermatology, University Hopsital Münster
University Hospital Muenster
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP